Eventide Asset Management, LLC
- SEC CIK
- 0001442891
- Latest filing
- Aug 14, 2026
MIRM holding history
Mirum Pharmaceuticals, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MIRM overviewAll 13F holders of MIRMFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,248,389
- Value
- $146.2M
- % of portfolio
- 2.0%
- Quarters held
- 16
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,248,389 | $146.2M | 2.0% | −160,482−11.4% | Reduced | Holders |
| Q1 2026 | 1,408,871 | $130.1M | 2.2% | −684,711−32.7% | Reduced | Holders |
| Q4 2025 | 2,093,582 | $165.4M | 2.6% | −428,981−17.0% | Reduced | Holders |
| Q3 2025 | 2,522,563 | $184.9M | 3.0% | −114,922−4.4% | Reduced | Holders |
| Q2 2025 | 2,637,485 | $134.2M | 2.4% | +110,485+4.4% | Added | Holders |
| Q1 2025 | 2,527,000 | $113.9M | 2.3% | −79,938−3.1% | Reduced | Holders |
| Q4 2024 | 2,606,938 | $107.8M | 2.0% | −838,425−24.3% | Reduced | Holders |
| Q3 2024 | 3,445,363 | $134.4M | 2.3% | −169,457−4.7% | Reduced | Holders |
| Q2 2024 | 3,614,820 | $123.6M | 2.1% | +314,420+9.5% | Added | Holders |
| Q1 2024 | 3,300,400 | $82.9M | 1.3% | +636,751+23.9% | Added | Holders |
| Q4 2023 | 2,663,649 | $78.6M | 1.3% | −1,294,930−32.7% | Reduced | Holders |
| Q3 2023 | 3,958,579 | $125.1M | 2.3% | +499,378+14.4% | Added | Holders |
| Q2 2023 | 3,459,201 | $89.5M | 1.5% | +1,400,000+68.0% | Added | Holders |
| Q1 2023 | 2,059,201 | $49.5M | 0.9% | +2,201+0.1% | Added | Holders |
| Q4 2022 | 2,057,000 | $40.1M | 0.8% | +782,000+61.3% | Added | Holders |
| Q3 2022 | 1,275,000 | $26.8M | 0.5% | +1,275,000 | New | Holders |